CLAIM #40679 · Medtronic PLC (MDT) · 2025Q4 earnings call · May 21, 2025 · due Apr 30, 2027
“So this will be immediately accretive to our EPS and help strengthen the construction to get back to high single-digit growth into '27.”
Thierry Pieton · CFO
PENDING
graded after results covering Apr 30, 2027 are reported
How to check this claim
Look at: Revenue growth rate (constant currency or reported, as company discloses) for fiscal year 2027
It came true if: FY2027 revenue growth rate between 7% and 9%
Where: Company income statement and management commentary (10-K / earnings call, FY2027 results)
Verify independently
SEC filings for MDT ↗ · Claim quote is verbatim from the 2025Q4 earnings call.